Jump to content


Photo

Change in Tasigna dosage?


  • Please log in to reply
7 replies to this topic

#1 WoofWoof

WoofWoof

    New Member

  • Members
  • Pip
  • 1 posts

Posted 01 June 2011 - 11:04 AM

I just received a call from my pharmacy that my Tasigna dosage has change. I was taking (2) 200mg/twice a day now it's gone to (2) 150mg/twice a day. My Oncs' ofiice confirmed the the doctor did change the dosage. Not that I'm worried about it  (yet) but has anyone else had  their dosage reduced?


I have cancer but it doesn't have me


#2 CallMeLucky

CallMeLucky

    Advanced Member

  • Members
  • PipPipPip
  • 216 posts
  • LocationCT

Posted 01 June 2011 - 12:04 PM

Per NCCN guidelines, both 300mg and 400mg dosages are approved for treatment.

I found this section in the guidelines rather interesting.

"In a phase III, randomized, open label, multicenter trial [Evaluating Nilotinib Efficacy and Safety in Clinical Trials-Nelwy Diagnosed Patients (ENESTnd) study, the efficacy and safety of nilotinib (300 mg or 400 mg twice daily) was compared to that of imatinib (400 mg once daily) in patients newly diagnosed chronic phase CML.  At 12 months, the rates of MMR (the primary endpoint) were 44% for the 300-mg dose and 43% for the 400-mg dose vs. 22% for imatinib.  The rates of CCyR by 12 months (80% for the 300-mg dose and 78% for the 400mg dose vs 65% for imatinib) were also higher for nilotinib than for imatinib.


Patient receiving nilotinib at either of the two dose levels had a significant improvement in the time to progression to the accelerated phase or blast crisis, as compared with those receiving imatinib.  The rate of progression to accelerated or blast phase was 4% with imatinib and less than 1% with nilotinib."

So at the very least it appears the two dosage levels are equally effective.  (I don't think the 1%-2% favoring 300 mg really means anything).  From what I have read the higher dosage of Tasinga is more relevant when dealing with relapsed CML or someone who has progressed to accelerated phase or blast crisis.


Date  -  Lab  -  Scale  -  Drug  -  Dosage MG  - PCR
2010/Jul -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 1.2%
2010/Oct -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0.25%
2010/Dec -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0.367%
2011/Mar -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0.0081%
2011/Jun -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0%
2011/Sep -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0.00084%
2011/Dec -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0%
2012/Mar -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0.004%
2012/Jun -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0%
2012/Sep -  MSKCC  -  Non-IS  -  Gleevec  - 400 - 0%
2012/Dec -  MSKCC  -  Non-IS  -  Sprycel  - 100 - 0%
2013/Jan -  Quest  -  IS  -  Sprycel  -  50-60-70  - 0%
2013/Mar -  Quest  -  IS  -  Sprycel  -  60-70  - 0%
2013/Apr -  CUMC  -  Non-IS  -  Sprycel  - 50 - 0.036%
2013/May -  CUMC  -  Non-IS  -  Sprycel  - 50 - 0.046%
2013/Jun -  Genoptix  -  IS  -  Sprycel  - 50 - 0.0239%
2013/Jul -  Genoptix  -  IS  -  Sprycel  - 70 - 0.0192%
2013/Jul -  Genoptix  -  IS  -  Sprycel  - 70 - 0.0034%
2013/Oct -  Genoptix  -  IS  -  Sprycel  - 70 - 0.0054%
2014/Jan -  Genoptix  -  IS  -  Sprycel  - 70 - 0.0093%
2014/Mar -  Genoptix  -  IS  -  Sprycel  - 100 - 0.013%
2014/Apr -  Genoptix  -  IS  -  Sprycel  - 100 - 0.0048%
2014/Jul -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2014/Nov -  Genoptix  -  IS  -  Sprycel  - 100 - 0.047%
2014/Dec -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2015/Mar -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2015/Jun -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2015/Sep -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2015/Dec -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2016/Mar -  Genoptix  -  IS  -  Sprycel  - 100 - 0.0228%
2016/Jun -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2016/Sep -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2016/Dec -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2017/Mar -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2017/Jun -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2017/Sep -  Genoptix  -  IS  -  Sprycel  - 100 - 0%
2017/Dec - Genoptix  -  IS  -  Sprycel  -  100 - 0%
 

 


#3 Trey

Trey

    Advanced Member

  • PS Beta Group
  • PipPipPip
  • 1,705 posts
  • LocationSan Antonio, Texas

Posted 01 June 2011 - 08:14 PM

300mg twice daily is now the recommended dosage.  Your Onc is just catching up.

Message was edited by: Trey



#4 CMLMN

CMLMN

    New Member

  • Members
  • Pip
  • 0 posts

Posted 01 June 2011 - 10:34 PM

Thanks for this information.  I'm going to check with my Dr.  Hoping that lower dosage will improve my rash side effect. 



#5 Trey

Trey

    Advanced Member

  • PS Beta Group
  • PipPipPip
  • 1,705 posts
  • LocationSan Antonio, Texas

Posted 02 June 2011 - 09:19 AM

I had a typo in my previous posting above, which I have now corrected.  I had originally left out the word "twice", but I assume you probably understood anyway.



#6 WoofWoof

WoofWoof

    New Member

  • Members
  • Pip
  • 1 posts

Posted 02 June 2011 - 10:04 AM

Trey- I did know what you meant, but there will still be a reduction in your pay this week. There's something about "Trey" missing the word "twice" that struck me funny.


I have cancer but it doesn't have me


#7 Trey

Trey

    Advanced Member

  • PS Beta Group
  • PipPipPip
  • 1,705 posts
  • LocationSan Antonio, Texas

Posted 02 June 2011 - 01:00 PM

Thrice is my favorite.  Twice is over-rated.



#8 WoofWoof

WoofWoof

    New Member

  • Members
  • Pip
  • 1 posts

Posted 02 June 2011 - 09:53 PM

Touche Trey!


I have cancer but it doesn't have me





1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users